Tajinder P. Singh, M.B.,B.S., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Transplantation | 80 | 2024 | 3300 | 11.120 |
Why?
|
Heart-Lung Transplantation | 15 | 2023 | 87 | 4.090 |
Why?
|
Waiting Lists | 17 | 2015 | 780 | 3.560 |
Why?
|
Graft Rejection | 25 | 2024 | 4505 | 2.440 |
Why?
|
Graft Survival | 19 | 2024 | 3900 | 2.040 |
Why?
|
Lung Transplantation | 9 | 2023 | 1309 | 1.520 |
Why?
|
Cardiomyopathy, Dilated | 9 | 2015 | 843 | 1.520 |
Why?
|
Tissue Donors | 11 | 2024 | 2389 | 1.460 |
Why?
|
Registries | 26 | 2023 | 8378 | 1.420 |
Why?
|
Primary Graft Dysfunction | 3 | 2021 | 112 | 1.320 |
Why?
|
Societies, Medical | 15 | 2022 | 3960 | 1.280 |
Why?
|
Tissue and Organ Procurement | 9 | 2022 | 986 | 1.270 |
Why?
|
Organ Transplantation | 6 | 2023 | 1177 | 1.210 |
Why?
|
Heart Failure | 21 | 2024 | 11860 | 1.130 |
Why?
|
Infant | 53 | 2024 | 36512 | 0.950 |
Why?
|
Child | 74 | 2024 | 80894 | 0.910 |
Why?
|
Heart Diseases | 8 | 2022 | 2819 | 0.880 |
Why?
|
Social Class | 3 | 2024 | 2008 | 0.870 |
Why?
|
Echocardiography, Doppler | 3 | 2020 | 899 | 0.860 |
Why?
|
Antilymphocyte Serum | 3 | 2023 | 491 | 0.840 |
Why?
|
Hospital Mortality | 8 | 2019 | 5367 | 0.810 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2024 | 2144 | 0.800 |
Why?
|
Risk Assessment | 21 | 2021 | 24316 | 0.780 |
Why?
|
Child, Preschool | 50 | 2024 | 42654 | 0.780 |
Why?
|
Survival Rate | 22 | 2023 | 12870 | 0.740 |
Why?
|
Thoracic Surgery | 3 | 2021 | 727 | 0.720 |
Why?
|
Heart Rate | 7 | 2010 | 4218 | 0.700 |
Why?
|
Adolescent | 61 | 2024 | 89182 | 0.700 |
Why?
|
Hospitals, Special | 1 | 2020 | 90 | 0.700 |
Why?
|
Heart Defects, Congenital | 12 | 2017 | 4713 | 0.680 |
Why?
|
Cardiomyopathies | 6 | 2015 | 2056 | 0.670 |
Why?
|
Oxygen Consumption | 7 | 2013 | 1882 | 0.670 |
Why?
|
Immunosuppressive Agents | 7 | 2023 | 4209 | 0.670 |
Why?
|
Lung Diseases | 4 | 2021 | 1925 | 0.650 |
Why?
|
Retrospective Studies | 50 | 2024 | 81768 | 0.630 |
Why?
|
Heart | 10 | 2022 | 4449 | 0.620 |
Why?
|
Exercise Test | 11 | 2013 | 2186 | 0.610 |
Why?
|
Heart-Assist Devices | 8 | 2019 | 1292 | 0.580 |
Why?
|
Heart Ventricles | 5 | 2013 | 3838 | 0.570 |
Why?
|
Physical Exertion | 3 | 2011 | 669 | 0.570 |
Why?
|
Donor Selection | 4 | 2019 | 240 | 0.570 |
Why?
|
Transposition of Great Vessels | 3 | 2010 | 580 | 0.530 |
Why?
|
Enalapril | 2 | 2024 | 316 | 0.530 |
Why?
|
Transplants | 1 | 2018 | 208 | 0.510 |
Why?
|
Postoperative Complications | 12 | 2024 | 15854 | 0.500 |
Why?
|
Kidney Transplantation | 2 | 2023 | 4300 | 0.500 |
Why?
|
Risk Factors | 35 | 2024 | 74954 | 0.490 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 3 | 2024 | 1517 | 0.480 |
Why?
|
Tacrolimus | 3 | 2023 | 750 | 0.470 |
Why?
|
Tomography, Emission-Computed | 7 | 2002 | 1126 | 0.450 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2010 | 1244 | 0.450 |
Why?
|
Myocarditis | 2 | 2015 | 803 | 0.430 |
Why?
|
Male | 79 | 2024 | 364870 | 0.430 |
Why?
|
Humans | 114 | 2024 | 768298 | 0.420 |
Why?
|
Time Factors | 23 | 2021 | 40267 | 0.420 |
Why?
|
Female | 81 | 2024 | 397050 | 0.410 |
Why?
|
Vasodilator Agents | 6 | 2010 | 990 | 0.400 |
Why?
|
Survivors | 2 | 2019 | 2382 | 0.390 |
Why?
|
United States | 29 | 2021 | 73144 | 0.390 |
Why?
|
Kaplan-Meier Estimate | 11 | 2019 | 6541 | 0.380 |
Why?
|
Heart Failure, Systolic | 1 | 2012 | 135 | 0.370 |
Why?
|
Exercise | 5 | 2010 | 5947 | 0.370 |
Why?
|
Liver Transplantation | 1 | 2023 | 2399 | 0.370 |
Why?
|
Infant, Newborn | 21 | 2024 | 26410 | 0.360 |
Why?
|
Ventricular Function | 1 | 2012 | 406 | 0.360 |
Why?
|
ABO Blood-Group System | 2 | 2010 | 381 | 0.360 |
Why?
|
Postoperative Period | 6 | 2012 | 1830 | 0.340 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1813 | 0.330 |
Why?
|
Multivariate Analysis | 11 | 2015 | 12092 | 0.330 |
Why?
|
Hypoplastic Left Heart Syndrome | 2 | 2024 | 595 | 0.330 |
Why?
|
Pediatrics | 2 | 2021 | 3624 | 0.330 |
Why?
|
Treatment Outcome | 28 | 2024 | 65365 | 0.320 |
Why?
|
Histocompatibility | 1 | 2010 | 322 | 0.320 |
Why?
|
Patient Selection | 5 | 2019 | 4265 | 0.320 |
Why?
|
Propanolamines | 2 | 2006 | 164 | 0.310 |
Why?
|
Follow-Up Studies | 17 | 2020 | 39405 | 0.300 |
Why?
|
Carbazoles | 2 | 2006 | 221 | 0.290 |
Why?
|
Coronary Vessel Anomalies | 2 | 2002 | 308 | 0.280 |
Why?
|
Proportional Hazards Models | 10 | 2019 | 12557 | 0.280 |
Why?
|
Coronary Circulation | 5 | 2002 | 1617 | 0.280 |
Why?
|
Kidney Diseases | 2 | 2014 | 2103 | 0.270 |
Why?
|
Socioeconomic Factors | 5 | 2022 | 7861 | 0.270 |
Why?
|
Coronary Vessels | 5 | 2020 | 3125 | 0.270 |
Why?
|
Young Adult | 18 | 2021 | 60048 | 0.270 |
Why?
|
Models, Statistical | 4 | 2015 | 5099 | 0.260 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2019 | 275 | 0.260 |
Why?
|
Glomerular Filtration Rate | 1 | 2014 | 2226 | 0.260 |
Why?
|
Multicenter Studies as Topic | 2 | 2011 | 1727 | 0.250 |
Why?
|
Organ Size | 5 | 2022 | 2268 | 0.250 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2001 | 644 | 0.250 |
Why?
|
Fontan Procedure | 4 | 2017 | 805 | 0.240 |
Why?
|
Extracorporeal Membrane Oxygenation | 5 | 2019 | 1482 | 0.230 |
Why?
|
Databases, Factual | 5 | 2021 | 8072 | 0.230 |
Why?
|
Age Factors | 7 | 2021 | 18472 | 0.230 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3412 | 0.220 |
Why?
|
Lymphatic Irradiation | 1 | 2004 | 115 | 0.220 |
Why?
|
Coronary Artery Disease | 2 | 2022 | 6566 | 0.220 |
Why?
|
Giant Cells | 1 | 2004 | 187 | 0.220 |
Why?
|
Recovery of Function | 2 | 2011 | 2990 | 0.210 |
Why?
|
Boston | 5 | 2024 | 9371 | 0.210 |
Why?
|
Exercise Tolerance | 1 | 2008 | 848 | 0.210 |
Why?
|
Incidence | 11 | 2021 | 21544 | 0.200 |
Why?
|
Autonomic Nervous System | 1 | 2007 | 709 | 0.200 |
Why?
|
Atrial Flutter | 1 | 2004 | 253 | 0.200 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 2491 | 0.200 |
Why?
|
Myocardial Ischemia | 2 | 2011 | 2139 | 0.190 |
Why?
|
Chi-Square Distribution | 4 | 2012 | 3438 | 0.190 |
Why?
|
Ventricular Remodeling | 1 | 2009 | 1281 | 0.190 |
Why?
|
Skeletal Muscle Ventricle | 1 | 2001 | 3 | 0.190 |
Why?
|
Hyperlipidemias | 1 | 2006 | 773 | 0.190 |
Why?
|
Electric Countershock | 1 | 2004 | 534 | 0.180 |
Why?
|
Antibodies | 2 | 2023 | 2425 | 0.180 |
Why?
|
Predictive Value of Tests | 3 | 2013 | 15455 | 0.180 |
Why?
|
Echocardiography | 5 | 2020 | 5044 | 0.180 |
Why?
|
Adaptation, Physiological | 1 | 2008 | 1315 | 0.180 |
Why?
|
Abnormalities, Multiple | 2 | 2019 | 1424 | 0.180 |
Why?
|
Tunica Intima | 1 | 2003 | 459 | 0.180 |
Why?
|
Adrenal Cortex Hormones | 1 | 2010 | 1890 | 0.180 |
Why?
|
Transplantation, Homologous | 3 | 2023 | 4834 | 0.180 |
Why?
|
Nitrogen Radioisotopes | 3 | 2010 | 44 | 0.180 |
Why?
|
Adult | 29 | 2022 | 223622 | 0.180 |
Why?
|
Lung | 4 | 2022 | 10087 | 0.170 |
Why?
|
Exercise Therapy | 1 | 2007 | 941 | 0.170 |
Why?
|
Annual Reports as Topic | 4 | 2019 | 36 | 0.170 |
Why?
|
Reoperation | 3 | 2019 | 4340 | 0.170 |
Why?
|
Isoantibodies | 1 | 2023 | 682 | 0.160 |
Why?
|
Vasodilation | 2 | 2003 | 968 | 0.160 |
Why?
|
Resource Allocation | 2 | 2014 | 354 | 0.160 |
Why?
|
Tricuspid Atresia | 1 | 2019 | 37 | 0.160 |
Why?
|
Biphenyl Compounds | 1 | 2024 | 1026 | 0.160 |
Why?
|
Growth | 1 | 2001 | 366 | 0.160 |
Why?
|
Body Size | 1 | 2022 | 463 | 0.160 |
Why?
|
Health Status Disparities | 1 | 2011 | 1882 | 0.160 |
Why?
|
Adenosine | 5 | 2010 | 816 | 0.160 |
Why?
|
Arteriosclerosis | 1 | 2003 | 1056 | 0.150 |
Why?
|
Tetrazoles | 1 | 2024 | 923 | 0.150 |
Why?
|
Carotid Arteries | 1 | 2003 | 943 | 0.150 |
Why?
|
Steroids | 1 | 2023 | 936 | 0.150 |
Why?
|
Leukemia | 1 | 2006 | 1526 | 0.150 |
Why?
|
Lymphoproliferative Disorders | 1 | 2022 | 529 | 0.150 |
Why?
|
Drug Combinations | 1 | 2024 | 2078 | 0.150 |
Why?
|
Pulmonary Atresia | 1 | 2019 | 159 | 0.150 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2024 | 1066 | 0.150 |
Why?
|
Digestive System Abnormalities | 1 | 2017 | 49 | 0.140 |
Why?
|
Cohort Studies | 11 | 2013 | 41791 | 0.140 |
Why?
|
Prognosis | 6 | 2022 | 30020 | 0.140 |
Why?
|
Biopsy | 3 | 2020 | 6808 | 0.140 |
Why?
|
Severity of Illness Index | 5 | 2021 | 15939 | 0.140 |
Why?
|
Cause of Death | 3 | 2014 | 3728 | 0.140 |
Why?
|
Coronary Angiography | 3 | 2022 | 4537 | 0.130 |
Why?
|
Diet | 1 | 2014 | 8097 | 0.130 |
Why?
|
Myocardium | 4 | 2020 | 4788 | 0.130 |
Why?
|
Residence Characteristics | 3 | 2010 | 2122 | 0.130 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 617 | 0.130 |
Why?
|
Ductus Arteriosus, Patent | 1 | 1997 | 216 | 0.120 |
Why?
|
Propensity Score | 1 | 2023 | 1955 | 0.120 |
Why?
|
Middle Aged | 15 | 2021 | 223463 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1161 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2011 | 10377 | 0.110 |
Why?
|
Bronchitis | 1 | 2014 | 196 | 0.110 |
Why?
|
Aged | 12 | 2021 | 171544 | 0.110 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2013 | 317 | 0.110 |
Why?
|
Regional Blood Flow | 2 | 2010 | 1502 | 0.100 |
Why?
|
International Cooperation | 4 | 2019 | 1438 | 0.100 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9261 | 0.100 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 2014 | 223 | 0.100 |
Why?
|
Parents | 1 | 2006 | 3596 | 0.100 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2012 | 61 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2004 | 2257 | 0.100 |
Why?
|
Respiration, Artificial | 3 | 2014 | 2721 | 0.100 |
Why?
|
Creatinine | 2 | 2014 | 1915 | 0.100 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2012 | 353 | 0.090 |
Why?
|
Databases as Topic | 2 | 2011 | 475 | 0.090 |
Why?
|
Hospitals, Pediatric | 2 | 2011 | 1876 | 0.090 |
Why?
|
Prostheses and Implants | 1 | 1997 | 1279 | 0.090 |
Why?
|
Inpatients | 2 | 2012 | 2569 | 0.090 |
Why?
|
Hemodynamics | 4 | 2013 | 4199 | 0.090 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2002 | 3411 | 0.080 |
Why?
|
Michigan | 2 | 2014 | 341 | 0.080 |
Why?
|
Ventricular Function, Left | 2 | 2019 | 3942 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2003 | 2587 | 0.080 |
Why?
|
Pulmonary Artery | 1 | 1998 | 1945 | 0.080 |
Why?
|
Palliative Care | 1 | 2024 | 3643 | 0.080 |
Why?
|
Hyperemia | 2 | 2001 | 224 | 0.080 |
Why?
|
Mass Screening | 1 | 2004 | 5451 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2003 | 3440 | 0.080 |
Why?
|
Dilatation, Pathologic | 1 | 2009 | 527 | 0.070 |
Why?
|
Sudden Infant Death | 1 | 2010 | 293 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3242 | 0.070 |
Why?
|
Pulse | 1 | 2007 | 218 | 0.070 |
Why?
|
Insurance, Health | 2 | 2009 | 2518 | 0.070 |
Why?
|
Logistic Models | 6 | 2015 | 13323 | 0.070 |
Why?
|
Ultrasonography | 3 | 2017 | 6001 | 0.070 |
Why?
|
Body Mass Index | 3 | 2010 | 13050 | 0.070 |
Why?
|
Blood Pressure | 2 | 2019 | 8541 | 0.070 |
Why?
|
Infant Mortality | 1 | 2011 | 757 | 0.060 |
Why?
|
Surgical Procedures, Operative | 1 | 1997 | 1937 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2004 | 5168 | 0.060 |
Why?
|
Physical Endurance | 1 | 2008 | 370 | 0.060 |
Why?
|
Patient Readmission | 1 | 2019 | 3312 | 0.060 |
Why?
|
Poisson Distribution | 1 | 2006 | 509 | 0.060 |
Why?
|
Treatment Failure | 1 | 2010 | 2664 | 0.060 |
Why?
|
Stroke Volume | 2 | 2024 | 5620 | 0.060 |
Why?
|
Fetal Diseases | 1 | 2009 | 916 | 0.060 |
Why?
|
HLA Antigens | 2 | 2023 | 1337 | 0.060 |
Why?
|
Cyclosporine | 1 | 2006 | 779 | 0.060 |
Why?
|
Antineoplastic Agents | 1 | 2006 | 13696 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2011 | 2437 | 0.050 |
Why?
|
Ventricular Dysfunction | 1 | 2004 | 144 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2011 | 1795 | 0.050 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2012 | 1335 | 0.050 |
Why?
|
Patient Compliance | 1 | 2013 | 2693 | 0.050 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 2 | 1999 | 541 | 0.050 |
Why?
|
Health Resources | 1 | 2009 | 950 | 0.050 |
Why?
|
Algorithms | 2 | 2014 | 14154 | 0.050 |
Why?
|
Heart Block | 1 | 2004 | 390 | 0.050 |
Why?
|
Minority Groups | 1 | 2009 | 1215 | 0.050 |
Why?
|
Histocompatibility Testing | 1 | 2024 | 716 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2012 | 6856 | 0.050 |
Why?
|
Liver | 1 | 2017 | 7570 | 0.050 |
Why?
|
Norwood Procedures | 1 | 2024 | 192 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4859 | 0.050 |
Why?
|
Echocardiography, Stress | 1 | 2022 | 139 | 0.050 |
Why?
|
Neprilysin | 1 | 2024 | 487 | 0.050 |
Why?
|
Disease Progression | 2 | 2013 | 13646 | 0.050 |
Why?
|
Anaerobic Threshold | 1 | 2001 | 52 | 0.050 |
Why?
|
Antigens, CD20 | 1 | 2022 | 199 | 0.050 |
Why?
|
Brachial Artery | 1 | 2003 | 373 | 0.050 |
Why?
|
Income | 1 | 2010 | 1877 | 0.050 |
Why?
|
Sampling Studies | 1 | 2002 | 616 | 0.050 |
Why?
|
Microspheres | 2 | 2001 | 789 | 0.050 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2006 | 579 | 0.040 |
Why?
|
Myocardial Stunning | 1 | 2000 | 67 | 0.040 |
Why?
|
Perfusion | 2 | 2002 | 1402 | 0.040 |
Why?
|
Reference Values | 1 | 2007 | 4941 | 0.040 |
Why?
|
Prospective Studies | 3 | 2024 | 54921 | 0.040 |
Why?
|
Linear Models | 1 | 2010 | 5878 | 0.040 |
Why?
|
Medicaid | 2 | 2013 | 2842 | 0.040 |
Why?
|
Cholesterol, HDL | 1 | 2006 | 1820 | 0.040 |
Why?
|
Neutropenia | 1 | 2005 | 893 | 0.040 |
Why?
|
Radioisotopes | 1 | 2001 | 517 | 0.040 |
Why?
|
Dogs | 2 | 2001 | 3846 | 0.040 |
Why?
|
Pulmonary Circulation | 1 | 2002 | 744 | 0.040 |
Why?
|
Acute Disease | 2 | 2006 | 7242 | 0.040 |
Why?
|
Triglycerides | 1 | 2006 | 2465 | 0.040 |
Why?
|
Heart Atria | 1 | 2004 | 1360 | 0.040 |
Why?
|
Echocardiography, Transesophageal | 1 | 2004 | 1095 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10776 | 0.040 |
Why?
|
Cholesterol | 1 | 2006 | 2912 | 0.040 |
Why?
|
Respiratory Mechanics | 1 | 2001 | 722 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2006 | 2398 | 0.030 |
Why?
|
Ammonia | 1 | 1998 | 248 | 0.030 |
Why?
|
Thrombocytopenia | 1 | 2005 | 1180 | 0.030 |
Why?
|
Electrocardiography | 1 | 2010 | 6409 | 0.030 |
Why?
|
Muscle Contraction | 1 | 2001 | 1208 | 0.030 |
Why?
|
Kidney | 1 | 2011 | 7063 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2024 | 1751 | 0.030 |
Why?
|
Age of Onset | 1 | 2003 | 3345 | 0.030 |
Why?
|
Child Development | 1 | 2007 | 2334 | 0.030 |
Why?
|
Cardiac Output | 1 | 1998 | 838 | 0.030 |
Why?
|
Recurrence | 2 | 2004 | 8501 | 0.030 |
Why?
|
Aortic Valve Insufficiency | 1 | 1999 | 577 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2009 | 4047 | 0.030 |
Why?
|
Piperazines | 1 | 2004 | 2552 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2003 | 2050 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2010 | 6670 | 0.030 |
Why?
|
Hypertension, Pulmonary | 1 | 2004 | 1597 | 0.030 |
Why?
|
Chest Tubes | 1 | 2014 | 153 | 0.030 |
Why?
|
Carbon Dioxide | 1 | 1998 | 1149 | 0.030 |
Why?
|
Chylothorax | 1 | 2014 | 83 | 0.030 |
Why?
|
Prevalence | 2 | 2009 | 15868 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3622 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2007 | 4981 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2004 | 2763 | 0.020 |
Why?
|
Ascites | 1 | 2014 | 338 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2024 | 5151 | 0.020 |
Why?
|
Radiopharmaceuticals | 2 | 2000 | 2734 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 3252 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2009 | 5511 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2007 | 14783 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12457 | 0.020 |
Why?
|
Odds Ratio | 2 | 2014 | 9681 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2001 | 5311 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 26373 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6350 | 0.020 |
Why?
|
Sex Distribution | 1 | 2014 | 2281 | 0.020 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2013 | 671 | 0.020 |
Why?
|
Anticoagulants | 1 | 2004 | 4842 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2013 | 59683 | 0.020 |
Why?
|
Drainage | 1 | 2014 | 1183 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2014 | 22292 | 0.020 |
Why?
|
Hospitalization | 2 | 2006 | 10844 | 0.020 |
Why?
|
Preoperative Period | 1 | 2009 | 563 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 14736 | 0.020 |
Why?
|
Vascular Resistance | 2 | 2002 | 940 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2011 | 809 | 0.020 |
Why?
|
Herpesvirus 6, Human | 1 | 2005 | 98 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 1997 | 5538 | 0.010 |
Why?
|
Health Care Costs | 1 | 1997 | 3267 | 0.010 |
Why?
|
Length of Stay | 1 | 1997 | 6516 | 0.010 |
Why?
|
Sulfones | 1 | 2004 | 448 | 0.010 |
Why?
|
Purines | 1 | 2004 | 615 | 0.010 |
Why?
|
Ultrasonography, Prenatal | 1 | 2009 | 1767 | 0.010 |
Why?
|
Carbon Radioisotopes | 1 | 2000 | 567 | 0.010 |
Why?
|
Myocardial Reperfusion | 1 | 2000 | 339 | 0.010 |
Why?
|
Patient Discharge | 1 | 2011 | 3474 | 0.010 |
Why?
|
Poverty | 1 | 2009 | 2721 | 0.010 |
Why?
|
Administration, Oral | 1 | 2004 | 4043 | 0.010 |
Why?
|
Defibrillators, Implantable | 1 | 2004 | 1498 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 2000 | 1527 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 2004 | 2258 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1999 | 2226 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 2005 | 3211 | 0.010 |
Why?
|
Animals | 2 | 2001 | 169322 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2000 | 2056 | 0.010 |
Why?
|
Hypertension | 1 | 1991 | 8615 | 0.010 |
Why?
|
Chronic Disease | 1 | 2004 | 9380 | 0.010 |
Why?
|
Glucose | 1 | 2000 | 4354 | 0.000 |
Why?
|
Pregnancy | 1 | 2009 | 30198 | 0.000 |
Why?
|
India | 1 | 1991 | 2324 | 0.000 |
Why?
|